TXMD Dividend: TherapeuticsMD Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

TXMD Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2	1	1	69	2	64
Revenue Growth (YoY)	--	0%	-99%	3,350%	-97%	31%
Cost of Revenue	--	--	0	1	1	15
Gross Profit	--	--	1	68	1	48
Selling, General & Admin	4	4	8	57	80	192
Research & Development	--	--	--	0	0	10
Operating Expenses	5	5	9	57	80	204
Other Non Operating Income (Expenses)	2	2	0	0	0	0
Pretax Income	0	-2	-7	1	-79	-183
Income Tax Expense	0	0	0	0	0	0
Net Income	0	-2	-10	112	-172	-183
Net Income Growth	-100%	-80%	-109%	-165%	-6%	4%
Shares Outstanding (Diluted)	11.57	11.53	10.44	9.37	7.96	5.51
Shares Change (YoY)	0%	10%	11%	18%	44%	12%
EPS (Diluted)	-0.04	-0.2	-0.98	11.95	-21.66	-33.29
EPS Growth	-91%	-80%	-108%	-155%	-35%	-7%
Free Cash Flow	0	0	-48	-4	-144	-161
Free Cash Flow Per Share	0	0	-4.59	-0.42	-18.09	-29.21
Gross Margin	--	--	100%	98.55%	50%	75%
Operating Margin	-100%	-300%	-800%	14.49%	-3,950%	-242.18%
Profit Margin	0%	-200%	-1,000%	162.31%	-8,600%	-285.93%
Free Cash Flow Margin	0%	0%	-4,800%	-5.79%	-7,200%	-251.56%
EBITDA	-2	-3	-8	11	-79	-154
EBITDA Margin	-100%	-300%	-800%	15.94%	-3,950%	-240.62%
D&A For EBITDA	0	0	0	1	0	1
EBIT	-2	-3	-8	10	-79	-155
EBIT Margin	-100%	-300%	-800%	14.49%	-3,950%	-242.18%
Effective Tax Rate	0%	0%	0%	0%	0%	0%